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ABSTRACT
XLF/Cernunnos is a core protein of the nonhomolo-
gous end-joining pathway of DNA double-strand
break repair. To better define the role of Cernunnos
in end joining, whole-cell extracts were prepared
from Cernunnos-deficient human cells. These
extracts effected little joining of DNA ends with
cohesive 5’ or 3’ overhangs, and no joining at all of
partially complementary 3’ overhangs that required
gap filling prior to ligation. Assays in which gap-filled
but unligated intermediates were trapped using
dideoxynucleotides revealed that there was no gap
filling on aligned DSB ends in the Cernunnos-
deficient extracts. Recombinant Cernunnos protein
restored gap filling and end joining of partially com-
plementary overhangs, and stimulated joining of
cohesive endsmorethantwentyfold.XLF-dependent
gapfillingwasnearlyeliminatedbyimmunodepletion
of DNA polymerase j, but was restored by addition
of either polymerase j or polymerase k. Thus,
Cernunnos is essential for gap filling by either poly-
merase during nonhomologous end joining, sug-
gesting that it plays a major role in aligning the two
DNA ends in the repair complex.
INTRODUCTION
XLF/Cernunnos is a recently discovered core protein
of the nonhomologous end-joining pathway of DNA
double-strand break (DSB) repair (1,2). In humans, deﬁ-
ciency in Cernunnos confers immunodeﬁciency and micro-
cephaly (2). Cernunnos has sequence and structural
similarity to XRCC4, to which it binds (1,3,4). In vitro,
Cernunnos stimulates ligation of DNA ends by the
XRCC4/DNA ligase IV complex (X4L4), particularly
noncomplementary ends (5,6). To further deﬁne the func-
tion of Cernunnos, end joining was examined in
Cernunnos-deﬁcient whole-cell extracts, complemented
with puriﬁed recombinant Cernunnos protein. The results
indicate a speciﬁc requirement for Cernunnos in gap ﬁlling
on aligned DSB ends.
METHODS
Cells and extracts
Cernunnos-deﬁcient BuS ﬁbroblasts were isolated from
an RS-SCID (severe combined immune deﬁciency with
radiosensitivity) patient, and were immortalized by
h-TERT and SV40. The cells were grown in RPMI1640
medium plus 10% fetal bovine serum. These cells harbor a
homozygous nonsense mutation at R178 of Cernunnos
(2). Monolayers (5000cm
2 total) were harvested two
days after reaching conﬂuence (which appeared to
improve the end joining proﬁciency of extracts), and
whole-cell extracts were prepared by Dounce homogeni-
zation as described previously (7,8) (see Supplementary
Material). Extracts typically contained 10–13mg/ml pro-
tein in 20mM Tris pH 8, 0.1M potassium acetate, 1mM
dithiothreitol, 0.5mM EDTA, 20% glycerol (ﬁnal dialysis
buﬀer). For some experiments, the extracts were
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plemented with recombinant pol  (gift of Drs Kasia
Bebenek and Tom Kunkel, NIEHS) or polm (gift of Luis
Blanco, Universidad Auto ´ noma de Madrid) as described
previously (9).
Inhibitors
The kinase inhibitors 2-morpholin-4-yl-6-thianthren-
1-yl-pyran-4-one (KU-55933) and 2-N-morpholino-
8-dibenzothiophenyl-chromen-4-one (KU-57788 or
NU7441) were obtained from KUDOS and were stored
at  208C in DMSO. KU-55933 inhibits ATM with an
IC50 of 13nM, versus 1.8mM for DNA-PK (10). KU-
57788 inhibits DNA-PK with an IC50 of 14nM, versus
>100mM for ATM (11). Both are at least 100-fold more
potent in inhibiting their target kinase than any of 60
other kinases tested.
Substrates
To generate an internally labeled substrate with partially
complementary ( ACG/ ACG) overhangs, one labeled
and one unlabeled oligomer were ligated into 10- or 11-
base 50 overhangs of 30-resected plasmid pRZ56, as
described previously (8,12,13). To generate a labeled sub-
strate with cohesive 4-base 50 overhangs, pUC19 was cut
with BsaI, dephosphorylated, and 50-
32P end-labeled with
ATP and T4 polynucleotide kinase. To generate a sub-
strate with 4-base 30 overhangs, the same labeled DNA
was religated and cut with KpnI. In all cases, linear
full-length monomers were gel-puriﬁed, concentrated by
ﬁltration (Amicon Centricon 100) and precipitated.
Concentration was determined from A260.
Cernunnos protein and site-directed mutagenesis
For expression in Escherichia coli, the full-length
Cernunnos gene was cloned into plasmid pQE80 with an
N-terminal 6  His tag. Mutants S245A, S251A and the
corresponding double mutant were generated using the
QuickChange site-directed mutagenesis kit (Stratagene),
and the following primers determined by the
QuickChange Primer Design Program (Stratagene). For
S245A: CATACCTCAAACAGTGCTGCCCTGCAAG
GAATCG and CGATTCCTTGCAGGGCAGCACTGT
TTGAGGTATG. For S251A: GCTTCCCTGCAAGG
AATCGATGCCCAATGTGTAAACCAGC and GCTG
GTTTACACATTGGGCATCGATTCCTTGCAGGG
AAGC.
Plasmids harboring mutant or wild-type Cernunnos
cDNA were freshly transformed into E. coli BL21(DE3)
strain and cells were grown in 1l LB medium supplemen-
ted with 100mg/ml ampicillin. At an optical density
(600nm) of 0.4, IPTG was added to 1mM for induction.
Four hours later, cells were harvested and the dry pellets
were stored at  808C until use.
Cell pellets were resuspended in 12ml lysis buﬀer
(50mM NaH2PO4, pH 8.0, 0.3M NaCl, 10mM imidazole,
1mg/ml lysozyme, 1mM phenylmethylsulphonyl ﬂuo-
ride). After 30min on ice, cells were sonicated 6 15s
on 30% power (Sonicator from Ultrasonic Inc.). Crude
extracts were centrifuged at 14000g at 48C for 30min.
Soluble proteins were mixed with 1.5ml Qiagen Ni-NTA
Superﬂow beads and gently stirred 1h at 48C. The suspen-
sion was then added to a chromatography column and
washed with 25ml of wash buﬀer (50mM NaH2PO4,p H
8.0, 0.3M NaCl, 20mM imidazole, 1mM phenylmethyl-
sulphonyl ﬂuoride). Bound proteins were then eluted four
times with 1ml of the same buﬀer containing 0.5M imi-
dazole. All four fractions were analyzed by SDS–PAGE
electrophoresis and peak fractions dialyzed against 20mM
Tris–HCl pH 8.0 overnight. Cernunnos wild-type and
mutant proteins were ﬁltered (0.22mm), loaded on a
MonoQ FPLC column (Pharmacia) and eluted with a gra-
dient of 0–0.8M NaCl in 20mM Tris–HCl pH 8.0.
Fractions were collected and analyzed by SDS–PAGE.
Cernunnos-containing fractions eluted at  0.75M NaCl
and were stored at  208C in the elution buﬀer plus 50%
glycerol. Final concentration of the protein was deter-
mined using Pierce BCA assay with BSA as standard,
and veriﬁed by quantiﬁcation of bands on gels stained
with SYPRO orange and scanned with a Typhoon ﬂuo-
rescence imager (GE Healthcare), which agreed within a
factor of 1.5 . Stock solutions of Cernunnos were diluted
at least 100-fold in end joining reactions.
For baculoviral expression of His-tagged Cernunnos,
the cDNA was inserted into pFastBac-HTB vector and
recombinant Cernunnos-expressing baculovirus was gen-
erated with the Bac-to-Bac baculovirus expression system
(Invitrogen, Carlsbad, CA, USA). Sf9 cells were infected
with Cernunnos baculovirus and harvested 60h after
infection. Cells were lysed in 50mM NaH2PO4,p H8 ,
0.5M NaCl, 5mM b–mercaptoethanol, 10% glycerol,
and the lysate was sonicated and then centrifuged for 1h
at 150000g. The supernatant was mixed with Ni-NTA-
agarose (Qiagen, Valencia, CA, USA) and incubated for
4h at 48C with rotation. The beads were packed into
a column and eluted with a linear gradient of imidazole
(0–500mM) in lysis buﬀer. Fractions containing the
protein were pooled and loaded onto a Superdex 200
(16/60) column (GE Healthcare, Piscataway, NJ, USA)
in CB buﬀer (50mM Tris–HCl, pH 7.9, 1mM EDTA,
1mM dithiothreitol, 5% glycerol, 0.1M KCl). Finally,
Cernunnos-containing fractions were loaded into a
Mono Q (HR 5/5) column and eluted with a linear gradi-
ent of 0.1 to 1M KCl in CB buﬀer. Fractions containing
Cernunnos protein from MonoQ column chromatography
were aliquotted, and stored at  708C.
End joining reactions
Reactions contained 50mM triethanolammonium acetate
pH 7.5, 1mM ATP, 1mM dithiothreitol, 50mg/ml BSA,
1.3mM magnesium acetate and dNTPs (or ddNTPs) at
100mM each. Typically, a 16-ml reaction contained 10 ml
of extract, resulting in a ﬁnal concentration of 8mg/ml
protein, 66mM potassium acetate and 16% glycerol,
and an eﬀective Mg
++ concentration of 1mM (taking
into account  0.3mM EDTA from the extract). Buﬀer
components were ﬁrst mixed with cell extract at 228C.
Cernunnos was added and the solution mixed by pipeting.
In some reactions, KU-57788 in DMSO or DMSO alone
(ﬁnal concentrations of 1mM and 2%, respectively) was
4056 Nucleic Acids Research, 2009, Vol. 37,No. 12added and the sample mixed by pipeting. Finally, sub-
strate (10–100ng) was added and the reaction again
mixed by pipeting, and placed in a 378C water bath, usu-
ally for 6h. Samples were deproteinized as described (13)
and either loaded directly onto 0.8% agarose gels, or cut
with BstXI and AvaI and analyzed on 20% polyacryla-
mide DNA sequencing gels. Storage phosphor screens
were exposed to frozen polyacrylamide or dried agarose
gels, and images were analyzed with ImageQuant 3.3
software.
RESULTS
Joining of partially complementary DNA ends in cell
extracts is completely dependent on Cernunnos
Previous work showed that whole-cell extracts from
several cell lines harboring Cernunnos mutations had a
severe deﬁciency in end joining of an EcoRI-cut plasmid,
and that the deﬁciency could be corrected by stable trans-
fection of Cernunnos cDNA (2). We have shown that a
variety of human cell extracts can join DNA ends bearing
partially complementary  ACG/ ACG 30 overhangs,
and that they do so almost exclusively by a mechanism
involving annealing of the terminal self-complementary
 CG/ CG, ﬁlling of the 1-base gap in each strand, and
ligation (8,13). Using an internally labeled plasmid sub-
strate, these end joining events are detected after BstXI/
AvaI cleavage as 43-base (head-to-tail) and 24-base
(head-to-head) labeled products on a denaturing gel
(Figure 1A).
Within the limits of detection of phosphorimaging,
there was no generation of either 43- or 24-base fragments
(<0.1%) when the substrate was incubated in extracts
of Cernunnos-deﬁcient ﬁbroblasts. This apparent repair
deﬁciency could be complemented by mixing the
Cernunnos-deﬁcient extract with a similar extract from
DNA-PKcs-deﬁcient M059J cells (Figure 1B), or by addi-
tion of puriﬁed recombinant Cernunnos (Figure 1C). As
with other human cell extracts, only two major repair
products, of 43 and 24 bases, were detected, corresponding
to accurate annealing, patching and ligation of the -ACG
overhangs. Treatment with BsaHI in addition to BstXI
and AvaI converted most of the 43-mer and about half
of the 24-mer to a 13-mer, conﬁrming the predicted GAC
GTC repair joint (Figure 1C). The remaining uncleaved
43- and 24-base products may have been resistant to
BsaHI due to incomplete repair of the opposite strand.
Cernunnos produced in E. coli was as eﬀective in support-
ing end joining as that produced in baculovirus-infected
insect cells (Figure 1D). A titration with limiting amounts
of Cernunnos revealed greater-than-linear concentration
dependence between 25 and 100nM, consistent with mul-
tiple molecules of Cernunnos being required, as suggested
by structural studies (Figure 1E).
Cernunnos is required for gap filling on aligned DSB
ends by polj or polk
To directly determine whether Cernunnos is involved
in gap ﬁlling, end joining reactions were performed in
the presence of ddTTP, which supports gap ﬁlling by
polymerases   and m, but blocks the ﬁnal ligation step.
In such reactions, the predicted 16-mer corresponding to
the elongated but unligated intermediate was detected
only in extracts supplemented with Cernunnos
(Figure 2A), implying that gap ﬁlling in these extracts is
completely dependent on Cernunnos. Some ligation pro-
ducts were still generated in the presence of ddTTP, prob-
ably due to residual dTTP in the extracts, which are
dialyzed for only 3hr after ultracentrifugation (7). End
joining of the partially complementary substrate in the
presence of dTTP (Figure 2B), as well as gap ﬁlling
in the presence of ddTTP, was almost completely abol-
ished by immunodepletion with antibodies to pol , and
restored by addition of recombinant pol , suggesting
that pol  is the dominant Cernunnos-dependent gap-
ﬁlling polymerase (Figure 2C). However, addition of
polm promoted gap ﬁlling and end joining to the same
extent as pol  (ratio 1.1 0.1, N=3, for gap ﬁlling),
but again only in the presence of Cernunnos, indicating
that Cernunnos is required for gap ﬁlling by either poly-
merase. Taken together, these results indicate that
there was insuﬃcient polm activity in the extracts to sup-
port end joining; however, inasmuch as earlier results sug-
gested that polm is more susceptible than pol  to
nonspeciﬁc inactivation during immunodepletion (9), the
results do not exclude a signiﬁcant role for polm in gap
ﬁlling in vivo.
Cernunnos is required for efficient joining of cohesive 3’
and 5’ overhangs
Because gap ﬁlling is Cernunnos-dependent and must nec-
essarily precede ligation, the above results do not indicate
whether the ﬁnal ligation step also required Cernunnos.
To address this question, end joining of substrates bearing
fully cohesive ligatable overhangs was examined. End
joining of either a KpnI-cut plasmid bearing cohesive 4-
base 30 overhangs (Figure 3A) or a BsaI-cut plasmid bear-
ing cohesive 50 overhangs (Figure 3B) was almost comple-
tely dependent on Cernunnos, with a concentration
dependence similar to that for the partially cohesive over-
hang. However, in contrast to the partially cohesive sub-
strate, a trace of joining of the fully cohesive substrates
was detected in the absence of Cernunnos, typically
 0.5% with 20ng substrate and  2% with 100ng.
Nevertheless, end joining of the cohesive substrates was
stimulated as much as 75-fold by Cernunnos. While the
DNA-PK inhibitor KU-57788 blocked Cernunnos-depen-
dent end joining, the residual Cernunnos-independent end
joining was unaﬀected (Figure 3C). As reported previously
for DNA-PK-complemented M059J extracts (8), the
ATM inhibitor KU-55933 had no detectable eﬀect on
end joining at a concentration suﬃcient to block all
ATM-catalyzed phosphorylation (Figure 3C). Overall,
the results suggest that the ﬁnal ligation step of DNA-
PK-dependent end joining is also completely dependent
on Cernunnos, but that there is a low level of residual
end joining that does not require either Cernunnos or
DNA-PK.
Nucleic Acids Research, 2009,Vol.37, No. 12 4057Phosphorylation at S245 and S251 is not essential for
Cernunnos function in end joining in vitro
Recently, the dominant in vivo phosphorylation sites of
Cernunnos have been identiﬁed as S245, a DNA-PK-
dependent site, and S251, an ATM-dependent site (14).
To assess the possible functional role of these phosphor-
ylations, mutant Cernunnos proteins harboring S!A
mutations at one or both sites were produced in E. coli.
All these proteins supported end joining of the substrates
bearing either partially cohesive or fully cohesive 30 over-
hangs (Figure 4). These data imply that neither phosphor-
ylation at S245 nor at S251 is required for either gap ﬁlling
or ligation of 30 overhangs. The eﬃciency of end joining
with the mutant proteins was comparable to that with
wild-type, and there was no change in the ﬁdelity of
repair. The S245 and S251 phosphorylation sites also
appear to be dispensable for DSB repair in intact cells
(14). The ﬁnding that phosphorylation of the major sites
on Cernunnos is not essential, raises the possibility that
Cernunnos might only be required at a later stage in the
end joining pathway, after the essential phosphorylations
have been completed. However, order-of-addition experi-
ments (Supplementary Figure 1) indicated that in the
absence of Cernunnos there was little or no accumulation
A
BC
D
E F
Figure 1. Requirement for Cernunnos in joining of partially complementary DNA ends. (A) Internally labeled ( ) substrate and head-to-tail repair
product. Following alignment, single-base gap ﬁlling (bolded T’s) and ligation, the repaired top strand yields a labeled 43-base AvaI/BstXI fragment.
Similar intermolecular joining of two left-hand ends yields a 24-base product. (B) Complementation of end joining deﬁciency in Cernunnos-deﬁcient
BuS cell extracts by mixing with DNA-PK-deﬁcient M059J extracts (1:2, 1:1 or 2:1 ratio) or by addition of Cernunnos protein (100nM). The
substrate (10ng) was incubated in extracts for 6hr, deproteinized and cut with BstXI and AvaI. (C) Partial cleavage of repair products with BsaHI,
to yield a 13–mer. (D) Titration of end joining with various concentrations of Cernunnos, prepared in E. coli or in baculovirus-infected insect cells as
indicated. (E) Quantitation of data from (D). (F) Coomassie-stained gels showing purity of His-tagged recombinant Cernunnos proteins ( ) (expected
Mr=35kDa). Cernunnos protein in (B and C) was from E. coli.
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C
Figure 3. Cernunnos dependence of joining of cohesive 50 and 30 overhangs. (A) A labeled plasmid (20ng) bearing cohesive 30 overhangs ( GTAC/
 GTAC) was incubated for 6h in BuS extracts supplemented with the indicated concentrations of Cernunnos. (B) Same as (A) except that the
substrate (20 or 100ng) had cohesive 50 overhangs (CGGA /TCCG ). (C) The 50-overhang substrate (100ng) was incubated for 6h in extracts
containing 0 or 100nM Cernunnos and either the DNA-PK inhibitor KU-57788 (1mM) or the ATM inhibitor KU-55933 (1mM). Reactions without
inhibitor contained an equivalent concentration of DMSO. End joining was analyzed by agarose gel electrophoresis.
A BC
Figure 2. Requirement for Cernunnos and pol  or polm in alignment-based gap ﬁlling. (A) The substrate shown in Figure 1A was incubated in BuS
cell extracts with or without recombinant Cernunnos for 6h as in Figure 1, except that ddTTP was added instead of dTTP in some samples as
indicated. The 16-mer band represents the gap-ﬁlled but unligated intermediate. (B) The same extracts were preincubated with beads coated with
antibodies against pol  (+) or preimmune antibodies ( ), then incubated with the substrate as in (A), but in the presence of all four dNTPs plus
recombinant recombinant pol  (70ng), polm (70ng) and/or Cernunnos as indicated. (C) Same as (B), except that all samples contained ddTTP to trap
unligated intermediates. Cernunnos in these experiments was isolated from E. coli.
Nucleic Acids Research, 2009,Vol.37, No. 12 4059of active, appropriately phosphorylated repair complexes
that could proceed to gap ﬁlling and ligation in the pres-
ence of DNA-PK inhibitor when Cernunnos was added.
Instead, successful end joining appears to require the
simultaneous presence of Cernunnos and catalytically
active DNA-PK.
DISCUSSION
Cernunnos was discovered as the gene defective in a subset
of SCID patients with accompanying microcephaly (2),
and independently as XLF, a binding partner of XRCC4
(1). It has a structure similar to that of XRCC4, with a
globular head and long a-helical tail (3,4). Cernunnos
binds to Ku as well as to XRCC4, and induces supershifts
of both Ku-DNA and XRCC4-DNA complexes in elec-
trophoretic mobility shift assays (3,15,16). The cellular
phenotype for Cernunnos deﬁciency is similar to that for
Ku or XRCC4, and includes radiosensitivity and failure to
rejoin a substantial fraction of radiation-induced DSBs
(2). In reactions with puriﬁed proteins, Cernunnos stimu-
lates ligation of DNA ends by X4L4, and confers an abil-
ity to join mismatched ends and protruding single strands,
albeit at low eﬃciency (5,6). All these results suggest
that Cernunnos is a core factor in the end joining repair
complex. The ﬁnding that alignment-based gap ﬁlling in
whole-cell extracts is completely dependent on Cernunnos
(Figure 2) suggests that, in addition to stimulating ligase
IV, Cernunnos is also important for DNA end alignment.
Previously, we (17) and others (18) have shown that
in extracts of CHO (hamster) cells, end joining events
requiring gap ﬁlling are completely dependent on Ku,
while resection-based joining events are not. We also
showed directly that X4L4 is required for gap ﬁlling,
both in hamster whole-cell extracts (19), and in human
nuclear extracts (9); furthermore, at least in the hamster
extracts, XRCC4 alone could not substitute for the X4L4
complex. Given that these various extract systems show
the same speciﬁcity in gap ﬁlling and the same requirement
for either pol  or polm, it appears reasonably certain that
they share the same basic gap ﬁlling process. Thus, from
all these data we infer that gap ﬁlling for nonhomologous
end joining requires the full complex of Ku, XRCC4,
DNA ligase IV and Cernunnos. The requirement for
Cernunnos in gap ﬁlling is consistent with a recent pro-
posal that end alignment is promoted by assembly of a
ﬁlament of alternating homodimers of Cernunnos and
XRCC4 (3). In principle, the Cernunnos dependence of
gap ﬁlling could be due to more speciﬁc interactions
between Cernunnos and pol  or polm, but gel mobility
shift experiments indicate that Ku and X4L4 are suﬃcient
to eﬃciently recruit either polymerase to DNA ends
(20–22). Nevertheless, a model in which Cernunnos is
required for proper positioning of the polymerase within
the repair complex, rather than for end alignment as such,
remains a formal possibility.
The polymerase complementation results (Figure 2)
are consistent with previous work showing that pol  and
polm have distinct but overlapping speciﬁcities. Either
polymerase can eﬃciently ﬁll in one-base gaps in aligned
DSB ends (22,23), but only pol  can ﬁll longer gaps (9)
and only polm can ﬁll gaps with no base pairing, for exam-
ple, when noncomplementary single-base 30 overhangs are
present on both ends (23). Nevertheless, as shown pre-
viously with HeLa nuclear extracts (9), immunodepletion
of pol  almost completely eliminates gap ﬁlling, suggest-
ing that the level of polm in the extracts is too low to
support robust gap ﬁlling. However, we previously
found that the activity of polm (but not pol ) was substan-
tially reduced when the recombinant enzyme was mock-
depleted from solution with pre-immune rabbit IgG (9),
and thus it is possible that polm in the extract is more
susceptible than pol  to nonspeciﬁc loss or inactivation
during the extraction procedure.
Previous studies with puriﬁed DNA-PKcs, Ku, Artemis,
XRCC4 and ligase IV indicate that all of these proteins
except ligase IV are extensively phosphorylated by DNA-
PK when they are incubated together in the presence of
DNA ends (24). However, only phosphorylation of DNA-
PKcs itself has been shown to be important for end joining
in cells, and phosphorylation of XRCC4 and Ku is appar-
ently dispensable (24). Our results with mutant Cernunnos
proteins not only conﬁrm a previous report that S245A
and S251A mutations do not aﬀect repair eﬃciency (14),
but also indicate that they do not aﬀect repair ﬁdelity.
As yet, we have been unable to detect gap ﬁlling on
aligned DSB ends when the partially complementary
( ACG/ ACG) DSB substrate is incubated with the
combination of Ku, DNA-PKcs, X4L4, Cernunnos, and
pol , either with or without inositol hexakisphosphate
–
––
–
A
B
C
D
Figure 4. Eﬀect of S!A mutations in Cernunnos on complementation
of end joining. (A) Sequence context of the S245 and S251 phosphor-
ylation sites. (B) The partially complementary substrate shown in
Figure 1A was incubated for 6h in BuS cell extracts supplemented
with wild-type or mutant Cernunnos protein from E. coli, as indicated.
(C) Quantitation of data from (A) and two replicate experiments. End
joining for the mutant proteins was normalized to wild-type. (D) Same
as (B), except that the substrate was KpnI-cut pUC19.
4060 Nucleic Acids Research, 2009, Vol. 37,No. 12(25), even though we have shown that each of these recom-
binant proteins is able to complement gap ﬁlling and
end joining of the same substrate in the corresponding
repair-deﬁcient extracts (8,9,13,19). Although it has been
reported that alignment-based gap ﬁlling and ligation can
be achieved with only puriﬁed recombinant Ku, X4L4 and
pol  or polm, this reaction requires high concentrations of
substrate, as well as polyethylene glycol to promote
macromolecular crowding. Moreover, these reactions are
inhibited by Cernunnos as well as DNA-PKcs, both of
which are required for the same reactions in cell extracts
(23,26). Thus, while it is diﬃcult to rigorously eliminate
the possibility that there is some artifact associated with
combining multiple recombinant proteins, the simplest
explanation of the available data is that there are addi-
tional components in cell extracts which, even if they are
not part of the core end-joining complex, are nevertheless
required for it to function properly.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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